AUD 0.06
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 | 18.76 Million AUD | 104.16% |
2023 | 9.19 Million AUD | 23.52% |
2022 | 7.44 Million AUD | 159.36% |
2021 | 2.86 Million AUD | -28.22% |
2020 | 3.99 Million AUD | -16.08% |
2019 | 4.76 Million AUD | -52.36% |
2018 | 9.99 Million AUD | 448.98% |
2017 | 1.82 Million AUD | -79.56% |
2016 | 8.9 Million AUD | 16.5% |
2015 | 7.64 Million AUD | 1952.45% |
2014 | 372.57 Thousand AUD | 385.15% |
2013 | 76.79 Thousand AUD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 3.39 Million AUD | 0.0% |
2024 Q4 | -4.85 Million AUD | 0.0% |
2024 FY | 5.93 Million AUD | -35.48% |
2023 Q4 | 4.38 Million AUD | 0.0% |
2023 Q2 | 5.23 Million AUD | 0.0% |
2023 FY | 9.19 Million AUD | 23.52% |
2022 Q2 | 2.27 Million AUD | 0.0% |
2022 FY | 7.44 Million AUD | 159.36% |
2022 Q4 | 5.16 Million AUD | 0.0% |
2021 Q2 | 789 Thousand AUD | 0.0% |
2021 Q4 | 2.08 Million AUD | 0.0% |
2021 FY | 2.86 Million AUD | -28.22% |
2020 Q4 | 2.05 Million AUD | 0.0% |
2020 Q2 | 1.94 Million AUD | 0.0% |
2020 FY | 3.99 Million AUD | -16.08% |
2019 FY | 4.76 Million AUD | -52.36% |
2019 Q2 | 2.43 Million AUD | 0.0% |
2019 Q4 | 2.28 Million AUD | 0.0% |
2018 FY | 9.99 Million AUD | 448.98% |
2018 Q4 | 9.73 Million AUD | 0.0% |
2018 Q2 | 264.99 Thousand AUD | 0.0% |
2017 FY | 1.82 Million AUD | -79.56% |
2017 Q2 | 2.01 Million AUD | 0.0% |
2017 Q4 | 192 Thousand AUD | 0.0% |
2016 FY | 8.9 Million AUD | 16.5% |
2016 Q4 | 11.93 Million AUD | 0.0% |
2016 Q2 | 3.02 Million AUD | 0.0% |
2015 Q3 | - AUD | -100.0% |
2015 FY | 7.64 Million AUD | 1952.45% |
2015 Q4 | 5.16 Million AUD | 0.0% |
2015 Q2 | 2.48 Million AUD | 0.0% |
2014 FY | 372.57 Thousand AUD | 385.15% |
2013 FY | 76.79 Thousand AUD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
4DMedical Limited | 31.48 Million AUD | 40.401% |
Adherium Limited | 267.7 Thousand AUD | -6909.26% |
Aroa Biosurgery Limited | 66.09 Million AUD | 71.613% |
Atomo Diagnostics Limited | 1.6 Million AUD | -1068.366% |
Anteris Technologies Ltd | 69.14 Million AUD | 72.865% |
Control Bionics Limited | 9.82 Million AUD | -90.964% |
CardieX Limited | 16.64 Million AUD | -12.704% |
Compumedics Limited | 26.88 Million AUD | 30.193% |
Cochlear Limited | 1.17 Billion AUD | 98.403% |
CleanSpace Holdings Limited | 11.35 Million AUD | -65.186% |
Cyclopharm Limited | 13.38 Million AUD | -40.23% |
EMVision Medical Devices Ltd | 12.83 Million AUD | -46.21% |
Nova Eye Medical Limited | 23.99 Million AUD | 21.784% |
HeraMED Limited | 6.78 Million AUD | -176.635% |
Imricor Medical Systems, Inc. | -1.11 Million AUD | 1781.605% |
ImpediMed Limited | 28.04 Million AUD | 33.084% |
InhaleRx Limited | 2.59 Million AUD | -624.33% |
LBT Innovations Limited | 1.1 Million AUD | -1595.032% |
Neurotech International Limited | 8.75 Million AUD | -114.34% |
OncoSil Medical Limited | 12.03 Million AUD | -55.849% |
PolyNovo Limited | 34.92 Million AUD | 46.269% |
Respiri Limited | 8.03 Million AUD | -133.532% |
SomnoMed Limited | 58.97 Million AUD | 68.182% |
Universal Biosensors, Inc. | 20 Million AUD | 6.181% |
Uscom Limited | 5.52 Million AUD | -239.925% |
Visioneering Technologies, Inc. | 9.63 Million AUD | -94.776% |